Beam Therapeutics, Inc. (BEAM)
28.15
+0.38
(+1.37%)
USD |
NASDAQ |
Dec 24, 12:59
28.08
-0.07
(-0.25%)
After-Hours: 13:59
Beam Therapeutics SG&A Expense (TTM): 110.20M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| ANI Pharmaceuticals, Inc. | 304.67M |
| Intellia Therapeutics, Inc. | 119.17M |
| Regeneron Pharmaceuticals, Inc. | 2.717B |
| Amicus Therapeutics, Inc. | 353.07M |
| Repligen Corp. | 276.62M |